|
業務類別
|
Biotechnology |
|
業務概覽
|
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against theprincipal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line. |
| 公司地址
| 56 Evergreen Drive, Portland, ME, USA, 04103 |
| 電話號碼
| +1 207 878-2770 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.immucell.com |
| 員工數量
| 73 |
| Ms. Elizabeth S. Toothaker |
Controller |
-- |
30/03/2026 |
| Ms. Bobbi Jo Brockmann |
Vice President, Sales and Marketing |
美元 302.21K |
14/04/2026 |
| Mr. Paul Olivier Te Boekhorst |
Director, President and Chief Executive Officer |
美元 69.23K |
24/04/2026 |
| Mr. Timothy C. Fiori |
Director, Secretary, Treasurer and Chief Financial Officer |
美元 182.69K |
24/04/2026 |
|
|
| Dr. David S. Tomsche, D.V.M. |
Chairman of the Board |
24/04/2026 |
| Dr. Anthony A. DiMarco |
Independent Director |
14/04/2026 |
| Mr. Paul R. Wainman |
Independent Director |
24/04/2026 |
| Dr. Gilles Guillemette |
Independent Director |
14/04/2026 |
| Mr. Paul Olivier Te Boekhorst |
Director, President and Chief Executive Officer |
24/04/2026 |
| Ms. Gloria J. Basse |
Independent Director |
24/04/2026 |
| Mr. Timothy C. Fiori |
Director, Secretary, Treasurer and Chief Financial Officer |
24/04/2026 |
| Ms. Kathy V. Turner |
Independent Director |
14/04/2026 |
|
|
|
|
